European Association of Urology
Guidelines
Education & Events
Join our events Join our events
On-demand education Learn at your own pace
Scholarships Enrich your capabilities
Exchange Programmes Urology beyond Europe
Education Educational Platforms Talent Incubator Programme Accreditation
Science & Publications
Publications Our publications
Research & Science Passionate about research?
About
Who we are Our mission and history
Our Board and Offices How we work
Join the EAU Find out about membership
Vacancies Contact
Guidelines

Non-muscle-invasive Bladder Cancer

Want to read the guideline in your own time? Download the PDF

Download full guideline

Looking for a quick overview? Check the pocket guidelines.

Download pocket guidelines
Full text guidelineSummary of ChangesPublications & AppendicesPanelRelated content
No results found
  • E-course: EAU Guidelines on Non-muscle Invasive Bladder Cancer
  • Podcast: Prof. Paolo Gontero reviews risk stratification for Non-Muscle Invasive Bladder Cancer
  • Managing Bladder Cancer Recurrence after Intravesical Therapy
  • Cheat Sheet: Non-muscle-invasive Bladder Cancer
  • Cheat Sheet: Non-muscle-invasive Bladder Cancer

Related content

We offer education, events and other related content to give you a better understanding of the Non-muscle-invasive Bladder Cancer guidelines.

E-course: EAU Guidelines on Non-muscle Invasive Bladder Cancer

This course compiles the most recent clinical guidelines edited by the EAU in relation to Non-muscle Invasive Bladder Cancer. The Non-muscle Invasive Bladder Cancer course is divided into 3 learning units. Each Learning Unit consists of multiple choice questions that you can answer by navigating to the corresponding chapter of the Non-muscle Invasive Bladder Cancer guideline. The questions are offered for self-assessment of your knowledge of the EAU Guidelines on Non-muscle Invasive Bladder Cancer.

Start learning

Podcast: Prof. Paolo Gontero reviews risk stratification for Non-Muscle Invasive Bladder Cancer

Generally speaking, while NMIBCs have a more favourable prognosis compared to their MI counterpart, they are not the same and seem to behave differently (i.e. some are relatively indolent, others have aggressive features). In this episode, Prof. Paolo Gontero (IT) explains why this is the case.

Listen to this podcast

Managing Bladder Cancer Recurrence after Intravesical Therapy

Patients with non-muscle-invasive bladder cancer (NMIBC) recurrence during or after chemotherapy can benefit from BCG instillations. BCG therapy is effective regardless of prior chemotherapy. For those who fail BCG treatment, additional strategies, including further BCG therapy, may improve outcomes.

Download pdf

Cheat Sheet: Non-muscle-invasive Bladder Cancer

Epidemiology, staging and diagnosis

Bladder cancer (BC) is the 7th most commonly diagnosed cancer in males. Bladder cancer incidence and mortality rates vary across countries. Approximately 75% of patients with BC are non-muscle-invasive bladder carcinomas (NMIBC).

Download pdf

Cheat Sheet: Non-muscle-invasive Bladder Cancer

Review the EAU Guidelines on the risk stratification and disease management of NMIBC with this Cheat Sheet.

Download pdf
About EAU
  • Who we are
  • How we work
  • Become a member
Services
  • MyEAU
  • Congress registrations
  • Abstract submission
Media
  • EAU News
  • EAU Newsletter
  • EAU Press Releases
Contact
  • EAU Central Office
    PO Box 30016
    NL-6803 AA ARNHEM
    The Netherlands

  • Contact us
About EAU
Who we areHow we workBecome a member
Services
MyEAUCongress registrationsAbstract submission
Media
EAU NewsEAU NewsletterEAU Press Releases
Contact

EAU Central Office
PO Box 30016
NL-6803 AA ARNHEM
The Netherlands

Contact us
European Association of Urology
Privacy PolicyDisclaimer